返回
M
Mengying Guo
hunan university of technology
4H指数
38论文数
68被引数
收录论文 7
发表时间
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trialcAMP偏向性GLP-1受体激动剂ecnoglutide与dulaglutide在服用二甲双胍单药治疗的2型糖尿病且血糖浓度升高的患者中的疗效与安全性比较(EECOH-2):一项为期52周、多中心、开放标签、非劣效性、随机、III期试验

